Articles published by Biosero, Inc.
 
   
    BD and Biosero Collaborate to Enable Robotic Integration with Flow Cytometers Used in Drug Discovery and Development
    
   January 23, 2025
   From Biosero, Inc.
   Via Business Wire
    Tickers
      BDX
    
    
   From Biosero, Inc.
   Via Business Wire
    
   
    Biosero Appoints Daniel Schumann as Chief Operations Officer
    
   March 13, 2024
   From Biosero, Inc.
   Via Business Wire
    
   
    Biosero Appoints Ryan Bernhardt as Chief Executive Officer
    
   September 07, 2023
   From Biosero, Inc.
   Via Business Wire
    
   
    Biosero Appoints Rob Harkness as Chief Technology Officer
    
   August 01, 2023
   From Biosero, Inc.
   Via Business Wire
    
    
    
   
    Biosero and AltemisLab Collaborate to Streamline Automated Sample Management Workflows
    
   February 07, 2023
   From Biosero, Inc.
   Via Business Wire
    
    
    
   
    Biosero Wins Innovation Award for Product of the Year
    
   August 02, 2022
   From Biosero, Inc.
   Via Business Wire
    
    
   
    Biosero Joins Genedata Ready-to-Run Program to Streamline Lab Automation and Data Analysis
    
   February 03, 2022
   From Biosero, Inc.
   Via Business Wire
    
   
    Biosero Collaborates with Araceli Biosciences for High-Content Analysis
    
   February 01, 2022
   From Biosero, Inc.
   Via Business Wire
    
   
    Biosero’s David Dambman Honored with CTO of the Year Award
    
   November 30, 2021
   From Biosero, Inc.
   Via Business Wire
    
   
    Biosero and Bio-Strategy Enter Into ANZ Distribution Agreement
    
   November 16, 2021
   From Biosero, Inc.
   Via Business Wire
    
   
    Biosero’s Tom Gilman Receives CEO of the Year Award
    
   June 24, 2021
   From Biosero, Inc.
   Via Business Wire
    
   From Biosero, Inc.
   Via Business Wire
   
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.